Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 agonists for diabetes, with new data for Mounjaro on cardiovascular outcomes. The results of the SURPASS-CVOT trial showed ...
The FDA has set up a 'green list' of overseas sources for weight-loss ingredients in an attempt to block illegitimate and potentially unsafe supplies entering the US market. The list identifies ...
I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy cooking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback